
IDXG
Healthcare · Diagnostics & Research · $35.7M market cap
$6.05-0.20 (-3.2%)Nov 13, 2:59 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 7, 2026 | Time not confirmed | — | 0.00 | — |
| Mar 5, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 13, 2025 | Time not confirmed | — | 0.04 | — |
| Aug 7, 2025 | Time not confirmed | — | -0.12 | — |
| May 19, 2025 | Time not confirmed | — | 0.06 | — |
| Mar 31, 2025 | Time not confirmed | — | 0.05 | — |
| Nov 4, 2024 | Time not confirmed | — | 0.31 | — |
| Aug 2, 2024 | Time not confirmed | — | 0.48 | — |
| May 9, 2024 | After the close | -0.25 | -3.35 | -1240.0% |
| Mar 7, 2024 | Time not confirmed | 0.11 | 0.00 | -100.0% |
| Nov 8, 2023 | After the close | -0.01 | -0.12 | -1100.0% |
| Aug 9, 2023 | After the close | -0.08 | 0.09 | +212.5% |
| May 12, 2023 | After the close | -0.19 | 0.10 | +152.6% |
Interpace Biosciences, Inc. provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States. It offers ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier. It primarily serves physicians, cancer centers,…
| Mar 27, 2023 |
| After the close |
| -0.07 |
| -0.37 |
| -428.6% |
| Nov 14, 2022 | After the close | -0.25 | -0.25 | 0.0% |
| Aug 15, 2022 | After the close | -0.52 | -0.99 | -90.4% |
| May 16, 2022 | After the close | -0.80 | -0.54 | +32.5% |
| Mar 31, 2022 | After the close | -0.32 | -0.90 | -181.3% |
| Nov 10, 2021 | After the close | -0.62 | -0.78 | -25.8% |
| Aug 10, 2021 | After the close | -0.48 | -0.63 | -31.3% |
| May 11, 2021 | After the close | -1.43 | -0.70 | +51.0% |
| Mar 31, 2021 | After the close | -1.32 | -1.56 | -18.2% |
| Oct 19, 2020 | After the close | -1.48 | -1.35 | +8.8% |
| Jun 25, 2020 | After the close | -1.24 | -1.30 | -4.8% |
| Nov 14, 2019 | After the close | -0.92 | -1.69 | -83.7% |
| Aug 13, 2019 | Before the open | -0.62 | -1.40 | -125.8% |
| May 13, 2019 | After the close | -0.56 | -0.96 | -71.4% |
| Mar 19, 2019 | After the close | -0.82 | -1.40 | -70.7% |
| Nov 13, 2018 | After the close | -0.74 | -0.95 | -28.4% |
| Aug 9, 2018 | After the close | -0.90 | -0.67 | +25.6% |
| May 15, 2018 | Before the open | -0.75 | -1.15 | -53.3% |
| Mar 15, 2018 | After the close | -1.03 | -1.10 | -6.8% |